Cita APA (7a ed.)
Murase, K., Lee, L., Ma, J., Barrett, R., & Thoolen, M. (2022). Evaluation of vatiquinone drug-drug interaction potential in vitro and in a phase 1 clinical study with tolbutamide, a CYP2C9 substrate, and omeprazole, a CYP2C19 substrate, in healthy subjects. European Journal of Clinical Pharmacology, 78(11), 1823-1832.
Cita Chicago Style (17a ed.)
Murase, Katsuyuki, Lucy Lee, Jiyuan Ma, Rosemary Barrett, y Martin Thoolen. "Evaluation of Vatiquinone Drug-drug Interaction Potential in Vitro and in a Phase 1 Clinical Study with Tolbutamide, a CYP2C9 Substrate, and Omeprazole, a CYP2C19 Substrate, in Healthy Subjects." European Journal of Clinical Pharmacology 78, no. 11 (2022): 1823-1832.
Cita MLA (9a ed.)
Murase, Katsuyuki, et al. "Evaluation of Vatiquinone Drug-drug Interaction Potential in Vitro and in a Phase 1 Clinical Study with Tolbutamide, a CYP2C9 Substrate, and Omeprazole, a CYP2C19 Substrate, in Healthy Subjects." European Journal of Clinical Pharmacology, vol. 78, no. 11, 2022, pp. 1823-1832.
Precaución: Estas citas no son 100% exactas.